329
Views
17
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Reviewing the safety of erlotinib in non-small cell lung cancer

, MD PhD, , MD FRCPC, , MD, , MD & , MD FACS
Pages 147-157 | Published online: 08 Dec 2010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.